Pharmaceutical Market Trends, 2008 - 2012: Key market forecasts & growth opportunities presents a detailed trend analysis of the global pharmaceutical market to the end of 2007 and forecasts until 2012. The 142 page report presents a series of market forecasts and growth opportunities in order to help inform pharmaceutical decision-making, particularly in the areas of corporate planning, portfolio management and market forecasting.
The data and analysis contained within the report are comprehensive, consistent and up-to-date in order to provide a single-point reference for understanding key pharmaceutical market trends in 2008.
HEADLINE FINDINGS INCLUDE
The global pharmaceutical market is forecast to grow to $929 billion in 2012, an equivalent compound annual growth rate (CAGR) of 5.5% over the next five years.
In 2007 the leading therapy areas by sales were CNS with 16.5% share and cardiovascular with 15.4%.
Four of the top 10 products in 2007 are forecast to increase sales over the next five years.
The US retail pharmaceutical market grew to $206 billion but growth rates fell due to loss of patent protection on some blockbusters
France, Germany and the UK together accounted for almost 50% of all European pharmaceutical sales in 2007.
The top 100 blockbuster drugs generated sales of $252.5 billion, accounting for 35.5% of the total pharmaceutical market.
The leading blockbuster by increased sales revenues in 2007 was the blood agent product Plavix (clopidogrel bisulfate), marketed by Sanofi-Aventis and Bristol-Myers Squibb.
There were a total of 61 companies generating pharmaceutical sales in excess of $1 billion in 2007
KEY FEATURES OF THE REPORT
Comprehensive market trends for key countries, regions, therapy areas, products and companies.
Country profiles for leading pharma markets with market segment trends and five year forecasts.
Therapy area profiles for leading therapeutic classes and key products and 2010 sales forecasts.
Detailed profiles of 10 leading pharmaceutical products in 2007, including five year future sales forecasts.
Detailed profiles of 10 leading pharmaceutical companies in 2007, including 2012 sales forecasts.(AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson and Johnson, Merck & Co, Novartis, Pfizer, Roche, Sanofi-Aventis Wyeth)
(0 items)
